United Press International - October 8, 2008
COLUMBIA, Mo., Oct. 8 (UPI) -- U.S. scientists say they have, for the first time, witnessed the human immunodeficiency virus mature from an inactive form into an active infection.
"We actually saw the process occur," said University of Missouri Assistant Professor Chun Tang, "We now understand more about the maturation process. We hope this will be a stepping stone to intervening before the infection progresses."
The researchers said the HIV-1 protease is responsible for releasing the essential building blocks of an infective HIV-1 viral particle that causes AIDS. But the HIV-1 protease -- one of the primary targets of therapeutic treatment -- is constantly mutating in an effort to gain drug resistance.
"HIV-1 protease is not an active enzyme when it is first expressed in cells. It has to be activated to do its job," Tang said. "What we were able to see is how it self-activates from an immature form when the virus is not infective into a mature form when the virus gains infectivity."
Tang and his colleagues saw the temporary joining of two halves of HIV-1 protease precursor -- something that has not been possible using conventional techniques.
The research is reported in the journal Nature.
Reference: Visualizing transient events in amino-terminal autoprocessing of HIV-1 protease. Nature. 2008 Oct 2;455(7213):693-6.
081008
UP081004
Copyright © 2008 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .